Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 7, 2002
Hepatitis C viral dynamics: basic concept and clinical significanceWolfgang Jessner, Thomas Watkins-Riedel, Elisabeth Formann, et al.The American Journal of Gastroenterology|January 13, 2006
Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis CCalin Gurguta, Clemens Kauer, Ulrike Bergholz, et al.Thrombosis and Haemostasis|February 24, 2006
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis CWolfgang Sieghart, Monika Homoncik, Bernd Jilma, et al.Antiviral Therapy|August 5, 2008
Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infectionWolfgang Jessner, Michael Gschwantler, Elisabeth Formann, et al.AIDS (London, England)|October 28, 2005
Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infectionLudwig Kramer, Harald Hofer, Edith Bauer, et al.The American Journal of Gastroenterology|October 13, 2006
Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapyMonika Homoncik, Wolfgang Sieghart, Elisabeth Formann, et al.The American Journal of Gastroenterology|May 7, 2004
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirinElisabeth Formann, Rudolf Stauber, Doris-Maria Denk, et al.Gynecologic Oncology|September 10, 2002
The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancerOliver Preyer, Andreas Obermair, Elisabeth Formann, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 18, 2006
Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfectionJudith H Aberle, Elisabeth Formann, Petra Steindl-Munda, et al.Journal of Hepatology|December 13, 2005
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infectionPeter Ferenci, Elisabeth Formann, Hermann Laferl, et al.Pageof 2